The FDA has issued a Request for Information on gluten labeling and cross‑contact controls for packaged foods, seeking public input as it reviews whether to require more transparent disclosure of gluten‑containing ingredients beyond wheat.
GFF encourages a detailed approach, highlighting that not all UPFs are created equal and that many grain-based foods offer essential nutrients that contribute to a healthy diet.
The FDA’s “no questions” letter means the agency has reviewed Onego Bio’s safety dossier and found no reason to challenge its conclusion that the product is safe for consumption.
The list of compounds being reviewed now includes the substances BHT, BHA, and ADA. Titanium dioxide, propylparaben, and phthalates are already included in the review’s purview.
According to the Federal Food, Drug, and Cosmetic Act (Chapter VII, section 721), colour additives must receive FDA approval to ensure their safety before being used in food.